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STRAND MULTIPRINT (PVT) ltd
Profile of the Nigerian sickle cell anaemia patients above
30 years of age
*A YETUNDE, **C C ANYAEGBU
Abstract
Objective: To examine the haematological profiles of patients with sickle cell anaemia above the age of 30 
years.
Design: Prospective cross sectional study.
Setting: Department of Haematology University College Hospital, Ibadan, Nigeria.
Subjects: 98 patients with sickle cell anaemia above the age of 30 years.
Main Outcome Measures: Clinical and haematological profiles of the patients.
Results: There were 75 females and 23 males. The steady state packed cell volume was 21 to 28% with a 
median of 24% Haemoglobin F (HbF) level in 33 patients was greater than 3% but less than 5%. Thirty six 
patients had a HbF which was greater than 5% but less than 10%. Twenty three patients had a HbF level which 
was greater than 10% but less than 15%. Five patients had a HbF level greater than 15% and only one patient 
had a HbF level of 22%.
The severe complications of sickle cell anaemia were not observed in 87 patients (88.8%), though some age 
related complications like Grade 4 ischaemic necrosis of the femoral head, chronic inflammatory liver 
changes and ophthalmic complications were observed. Eighty six patients had never had a blood transfusion, 
while 76 had never been admitted into hospital. Thirty four patients had a mild to moderate degree of 
splenomegaly while 64 patients had mild to moderate degree of hepatomegaly. Seven of the patients had 
chronic ulcers which spanned five to 12 years before the study. Five patients, however, had had cerebrovascular 
accidents. The cohort of patients with HbF level greater than 10% had not experienced priapism, acute chest 
syndrome, cerebrovascular accidents or chronic leg ulcer. All the patients have had a form of Western 
education, have a good knowledge of the disease and possible outcome.
Conclusion: The study strongly suggests that for the survival of the sickle cell anaemia patient, educational 
background of patients and their parents, awareness of hospital treatment and early presentation in hospital 
are major contributory factors. Also, adequate medical care, maintenance of disciplined life styles, stable or 
sedentary occupation and good family support, prompt and effective treatment of complications, all contribute 
to better health and hence a longer life span.
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Introduction
Haemoglobin S occurs with greatest prevalence in tropical 
Africa and clinicians have generally associated sickle cell 
disease with high morbidity and mortality.1-3
The heterozygous frequency in Nigeria is usually about 
25% but in some areas it reaches 32.5%.4 Patients with 
sickle cell anaemia (SCA) constitute about 2 to 3% of the 
Nigerian population. While the disease appears benign in 
some patients, it runs a crippling course in others. There are 
a few reports of patients surviving till the fourth or fifth 
decade but this is a very rare occurrence in Nigeria. Thus, 
patients over the age of 30 years form a very small 
proportion of the patients. It has been implied that inherited 
and acquired factors influence the pathogenesis and clinical 
symptoms of the disease.1 Hence, this results either in 
death in the early years in some patients or cases discovered 
late in life as a result of chance survey.1 With improvement 
in the living standard and increasing availability of health 
care, it has been observed that more patients with sickle 
cell anaemia in Nigeria survive into adolescence and 
maturity, and they are able to reproduce and some are in 
gainful employment.
Patients with SCA vary in thehaematological and clinical 
features of their disease.5 The observed variability of the 
clinical manifestations amongst SCA patients is thought to 
be genetically determined hence the genetic regulation of 
the rate of progression of sickle cell induced vasculopathy 
and the clinical expression of the disease while most 
clinical complications are thought to be age specific.6-8
Considerable knowledge has accumulated in the 
understanding of the physiology and pathogenesis of SCA 
more than in any other inherited disease. Extracellular 
factors that influence the disease include environmental 
factors, low oxygen tension, cardiac or respiratory disorders 
temperature and acidosis, while intra-cellular factors are 
genetically determined.7 The failure of the spleen to filter 
and effectively destroy polysaccharide encapsulated 
bacteria accounts for the high septicaemic death rate among 
SCA patients.
It is now clear that recent advances in treatment like the 
use of Hydroxyurea, and exchange transfusion regimes 
have enhanced the quality of life and some of thesepatients 
now live longer.
Owing to the dearth of information regarding SCA in 
those aged 30 or above, patients aged 30 years or more 
were studied and the observations recorded with regard to 
clinical and laboratory findings are presented.
Materials and Methods
Patients above 30 years of age diagnosed as having SCA 
who were attending the Medical Outpatient Department 
and who were in steady state were selected into the study 
at the Univers ity College Hospital, Ibadan, Nigeria between 
May 1996 and September 1998. Thehaematological profile 
and clinical evaluation of the patients were assessed. The 
steady state full blood count and reticulocyte counts were
recorded. Packed cell volume was estimated as the spun 
haematocrit and the mean cell haemoglobin concentration 
was calculated from this value. Foetal haemoglobin was 
estimated by alkaline denaturation. Steady state was defined 
as the absence of acute illness or any chronic condition- 
likely to influence the haematological profile. Systemic 
review was carried out on each patient. The spleen and 
liver sizes were measured.
Educational level and occupation of patients and their 
parents were noted. Age at menarche was noted , for the 
females and age at noticeable secondary sexual 
characteristics was noted for the males. Psychological 
assessment of their concept of the disease was noted, 
notably depression, dependence on opioids and sexuality.
Previous transfusion requirements, number of hospital 
admissions per year and painful crisis per year were noted.
Liver function tests, electrolyte, urea and creatinine 
were assessed. Past history of cerebrovascular accidents, 
occurrence of priapism, chronic leg ulcers and acute chest 
syndromes were noted.
Results
Of the 98 patients in the study, there were 75 females and 
23 males, giving a male to female ratio of 1:3. Age range 
was 30 to 52 years, the oldest being a female.
All the 98 patients had had some form of formal Western 
education. Twenty seven (25.5%) had a primary school 
leaving certificate, 23 (23.5%) had secondary school 
education and 48 (49%) were professionals. The 
professionals were comprised of accountants, bankers, 
engineers, teachers, nurses and hospital maids. All the 
patients were aware of the disease and had a good knowledge 
of the disease outcome.
Nine female (12% of female) patients started their periods 
between 13 to 15 years of age, 35 (46.6%) after 15 to 17 
years, 27 (36%) after 17 but before 20 years and two (2.6%) 
started after 20 years. Seven (7.1%) of the patients were 
observed to have chronic leg ulcers. The leg ulcers spanned 
a period of five to 12 years before the study. Eighty six 
(87.7%) patients had never had a blood transfusion, three 
patients had been transfused three times, four had two units 
and five had one unit each (Figure I). Seventy six (77.5%) 
patients have never been admitted to hospital, while 22 
have been admitted for mild to moderate infarctive bone 
pain crisis. Two patients had been admitted for skin graft 
of chronic leg ulcers during the course of the study. 
Haematological parameters of the patients showed packed 
cell volume (PCV) in the 21 to 28% range with a median 
of 24%. Second and third quartiles are 23 and 25% 
respectively. Reticulocyte counts were 1.2 to 7% with a 
median of 4.5%. Haemoglobin F in 33 patients was greater 
than three to less than 5%. Thirty six had HbF greater than 
5 % but less than 10%. Twenty three patients had HbF 
greater than 10% but less than 15%. Five patients had HbF 
level greater than 15%. One patient had a haemoglobin F 
level of 22% (Figure II).
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Figure I;Transfusion in SCA patients above 30.
Figure II: Haemoglobin F HbF level in SC patients above 
30 years.
HbF Level
Seventy patients (71.4%) had a normal range of urea and 
electrolytes. Three patients among the males have had 
priapism for which cavernospongiosal shunt procedure 
was carried out with consequent loss of penile erection. 
Five patients had a history of cerebro-vascular accidents 
which were managed, conservatively and had shown no 
residual damage. Of the 75 females, 53 (70.6%) were 
married and 47 (62.6%) had been pregnant, and 23 had 
carried normal uncomplicated pregnancies.
It is worth noting that 34 patients (35%) had a mild to 
moderate degree of splenomegaly while 64 patients had no 
palpably enlarged spleen. All the 98 patients had mild to 
moderate hepatomegaly.
Discussion
Previous reports have observed a haemoglobin F level of 
3 to 5%. in this environment.8 This trend was observed in 
only 33 (33.7%) patients in the present study. The 65 
patients (66.3%) having HbF in the five to 22% range are 
unusual for this environment. These patients, however, 
have been alive for 30 or more years. The clinical 
complications, the degree of anaemia and the clinical 
severity have shown some degree of correspondence with
.  \
the haemoglobin F level. For example the cohort of patients 
with haemoglobin F greater than 10% had no one with a 
history of cerebro-vascular accident, priapism or chronic 
leg ulcer. However, all have had a history of mild to 
moderate bone pain crisis and jaundice. Thus, the 
haemoglobin F level above 10% has not shown a protection 
against infarctive or haemolytic crises.
The 15 (15.3%) patients with features of gnathopathy, 
bossing of the forehead and some of the other features of 
the usual habitus of haemoglobin S were in the 3 to 5 % HbF 
range. This observation is in agreement with Powars who 
concluded that a Haemoglobin F level above 10% reduces 
bone pain crisis and end organ damage. The Haemoglobin 
F level greater than 10% no doubt has some degree of 
protection against severe clinical complications in the 
sickle cell anaemia patient. All the patients had very few 
bone pain crises per year and had shown a good clinical 
severity score since diagnosis. In the study, a high 
percentage of patients had never been hospitalized nor had 
a blood transfusion for anaemia. The Haemoglobin F level 
however, did not show any significant difference between 
the females and males. The packed cell volume also did not 
exhibit any significant difference between the males and 
females. Though some age related complications are 
observed, the reticulocyte count, however showed no 
obvious relationship with level of haemoglobin F.
It is, however, noteworthy that all the patients had 
received some form of Western education. This may account 
for their heightened awareness of the nature of the disease 
and knowing the importance of hospital management and 
prompt medical consultation in time of any emergency. 
The only constraints might be finances or transport to the 
hospital. Eighty two per cent of the same cohort of patients 
admitted having parents especially mothers who are aware 
of the nature of their disease; mothers who are quite 
sympathetic and supportive. Only 14 (14%) reported that 
their mothers occasionally show frustration especially 
when they have to take care of more than one child in the 
family that has SCA. It is worth noting, however, that the 
location of the study could also have an influence on the 
relatively high number of (SCA) patients above 30 years. 
The easy accessibility to the teaching hospital, and ready 
availability of health care facilities would have facilitated 
the management of these patients and so avoided or 
prevented early death.
The results of the study strongly suggested that for the 
survival of SCA patients, educational background, 
awareness of the hospital treatment are major contributory 
factors. Where parents are aware of the complications of 
the disease, prompt medical care, compliance to drug 
therapy and regular follow up are the rule, thereby reducing 
the morbidity and mortality that might arise from the 
disorder. Also early diagnosis, improved medical care, 
better knowledge of preventable complications of SCA by 
thh patients and their families have contributed to an 
increase in the 1 ife-span of these patients. It is also observed 
that selected health oriented and disciplined life styles,
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stable or sedentary occupation, and good family support
contribute to better health.
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